|
|
|
|
||
Re: Demand Elasticity and Afrezza's PricingMNKD has 12,000 people on Afrezza vs 4 Million on insulin......Yes that's INFLUENCE. Ha ha Come on......Like I said The Big 3 is putting pressure on Insurance companies and the FDA. Nothing will be done until MNKD takes measures to improve the label. Remember MNKD is in this position because of the LABEL. SANOFI killed the deal because of the LABEL. Sanofi knew what it would take for Afrezza to become a mainstream drug. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
16969 | Re: Demand Elasticity and Afrezza's Pricing | tocentsworth | 3 | 2/17/2020 11:31:32 AM |